PHASE 3 STUDY OF IBRUTINIB IN COMBINATION WITH VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA (MCL)
Tam, C.S., Rule, S., Le Gouill, S., Vitolo, U., Tsao, L.C., Cavazos, N., Beaupre, D.M., Wang, M.L.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2440_4
Date:
June, 2017
File:
PDF, 102 KB
english, 2017